Revisional bariatric surgery showed a positive impact on antidiabetic treatment reimbursement over a 4-year follow-up, reducing or discontinuing treatments and decreasing costs per patient. A study in France compared different revisional surgery sequences after sleeve gastrectomy and adjustable gastric banding, revealing significant changes in reimbursed antidiabetic treatments. These findings suggest the potential cost-effectiveness of revisional […]

Post-bariatric surgery statin discontinuation poses significant risks for ASCVD events, particularly in patients with prior ASCVD and certain demographics like Hispanics. Primary prevention patients have an 82% reduced risk of post-statin cessation ASCVD events compared to secondary prevention patients. Individualized healthcare strategies are needed, especially for those over age 40 with diabetes. Comprehensive cardiovascular evaluations […]

Patients with obesity overwhelmingly prefer metabolic bariatric surgery (MBS) options that offer significant weight loss without recurrence, no risk of complications, and minimal adverse effects. Two main patient groups emerged: those prioritizing weight loss and those prioritizing avoidance of complications. Attributes like out-of-pocket costs and resolution of medical conditions were deemed less critical. Understanding these […]

Study reveals that patients with lower polygenic risk scores for high BMI experience better weight loss outcomes after bariatric surgery. Genetic background, along with individual factors such as biological sex and age, plays a significant role in determining the success of surgical interventions for severe obesity. Results suggest that polygenic risk scores could serve as […]

Study developed a predictive model – GAASThyriC – utilizing age, glucose, TSH, alcohol use, SII, and tobacco to forecast patient outcomes post laparoscopic sleeve gastrectomy. The GAASThyriC score demonstrated high accuracy in identifying individuals unlikely to have optimal responses in weight loss. This model serves as a valuable tool for clinicians to anticipate patient populations […]

Adherence to post-surgery dietary recommendations significantly impacts weight loss success after metabolic and bariatric surgery. Factors like pre-surgery BMI, type of surgery, age, physical activity, and depression symptoms also play a role. Adherence peaks within 6 months post-surgery, highlighting the importance of ongoing support and behavior modification interventions for long-term success in managing severe obesity. […]

Sleeve gastrectomy surgery led to a significant reduction in hyperuricemia prevalence, improving metabolic syndrome status in patients with obesity. After one year, there was a 46.75% decrease in hyperuricemia cases among females and a 44.44% decrease among males. Enhancements in anthropometric and laboratory measurements were observed, highlighting the clinical relevance of this surgical intervention in […]

Following bariatric surgery, patients with gout benefited from uric acid-lowering medication, exhibiting reduced gout attacks and serum uric acid levels. Patients who continued medication showed fewer gout attacks and decreased serum uric acid levels after 6 months, compared to those who did not receive treatment. This highlights the importance of postoperative uric acid-lowering therapy in […]

Metabolic and bariatric surgery (MBS) is effective for sustained weight loss in chronic kidney disease (CKD) patients, with acceptable complication rates. Roux-en-Y gastric bypass (RYGB) leads to higher weight loss percentages but carries a higher risk of late surgical complications compared to sleeve gastrectomy (SG). CKD patients undergoing MBS saw improvements in kidney function, with […]